SEC Form 4 · accession 0001209191-18-001017
Alaunos Therapeutics, Inc. · TCRT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott Tarriff
Director
Period of report
Dec 29, 2017
Accepted (ET)
Jan 3, 2018 · 5:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001107421
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option Grant (Right to Buy)F1 | $4.14 | Dec 29, 2017 | A | 25,000 | A | — | Dec 29, 2027 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F125,000 shares shall vest on 12/29/2018.